An Educational Program

Program Directors:

Peter P. Liu, M.D., F.R.C.P.(C.), F.A.C.C.
Heart and Stroke/Polo Chair Professor of Medicine; Director, Heart and Stroke/ Richard Lewar Centre of Excellence in Cardiovascular Research, University of Toronto and Toronto General Hospital/ University Health Network Toronto

John D. Parker, M.D., F.R.C.P.(C.), F.A.C.C.
Pfizer Chair in Cardiovascular Research, Professor of Medicine and Pharmacology, University of Toronto; Head Division of Cardiology, UHN and Mount Sinai Hospitals Toronto

FACULTY:

University of Toronto Faculty

Peter H. Backx, D.V.M., Ph.D.
Professor, Departments of Physiology and Medicine, University of Toronto

Diego H. Delgado, M.D.
Assistant Professor, Department of Medicine, University of Toronto; Division of Cardiology, Heart Failure and Transplant Program, Toronto General Hospital/UHN

Paul Dorian, M.D., M.Sc., F.R.C.P.(C.)
Professor of Medicine, University of Toronto; Director, Electrophysiology Service, Division of Cardiology, St. Michael’s Hospital

Ren-Ke Li, M.D., Ph.D.
Professor, Department of Surgery, University of Toronto; Senior Scientist, Toronto General Research Institute, UHN

Susanna S. S. Mak, M.D., Ph.D., F.R.C.P.(C.),
Assistant Professor of Medicine, University of Toronto; Attending Cardiologist, Mount Sinai Hospital

Gordon W. Moe, M.D., F.R.C.P.(C.), F.A.C.C.
Associate Professor, Division of Cardiology, Department of Medicine; Attending Cardiologist, St. Michael’s Hospital

Kumaraswamy Nanthakumar, M.D., F.R.C.P.(C.)
Cardiologist and Electrophysiologist, Toronto General Hospital/ UHN

Gary E. Newton, M.D., F.R.C.P.(C.)
Assistant Professor of Medicine, University of Toronto; Attending Cardiologist, Mount Sinai Hospital

Vivek Rao, M.D., Ph.D., F.R.C.S.(C.)
Assistant Professor of Surgery; Surgical Director, Cardiac Transplant and Mechanical Assist, Toronto General Hospital/UHN

Heather Ross, M.D., M.H.Sc., F.R.C.P.(C.)
Associate Professor, Divisions of Cardiology and Transplant, University of Toronto; Medical Director, Cardiac Transplant Program, Toronto General Hospital/UHN

Duncan Stewart, M.D., F.R.C.P.(C.), F.A.C.C.
Dexter Hung-Cho Man Chair and Director, Division of Cardiology, University of Toronto, St. Michael’s Hospital

Richard D. Weisel, M.D., F.R.C.S.(C.), F.A.C.C.
Professor and Chair, Division of Cardiac Surgery, University of Toronto; Staff Surgeon, Division of Cardiovascular Surgery, Toronto General Hospital/UHN

E. Douglas Wigle, M.D., F.R.C.P.(C.), F.A.C.C.
Professor, Department of Medicine, University of Toronto; Attending Cardiologist, Toronto General Hospital/UHN

Peter W. Zandstra, Ph.D.
L’Anson Associate Professor of Tissue Engineering, Canada Research Chair in Stem Cell Bioengineering, Institute for Biomaterials and Biomedical Engineering, University of Toronto

Guest Faculty:

Piero Anversa, M.D.
Professor and Vice Chairman, Department of Medicine, Director of Cardiovascular Research Institute, New York Medical College New York

J. Malcolm O. Arnold, M.D., F.R.C.P.(C.), F.A.C.P., F.A.C.C.
Professor of Medicine, Physiology and Toxicology, University of Western Ontario; Program Leader, Circulation Group, Lawson Health Research Institute London, Ontario, Canada

Jay N. Cohn, M.D., F.A.C.C.
Professor of Medicine; Director, Rasmussen Center for Prevention of Cardiovascular Disease, University of Minnesota Medical School Minneapolis

Michael S. Ewer, M.D., J.D.
Professor of Medicine, University of Texas; Cardiology Department, M.D. Anderson Cancer Center Houston

Thomas Force, M.D.
Investigator, Molecular Cardiology Research Institute, Tufts-New England Medical Center; Professor of Medicine, Tufts University School of Medicine Boston

Mihai Gheorghiade, M.D., F.A.C.C.
Associate Chief, Division of Cardiology; Chief, Cardiology Clinical Service; Clinical Practice Director and Professor of Medicine, Northwestern University Feinberg School of Medicine Chicago

Anil Gupta, M.D., F.R.C.P.(C.)
Staff Cardiologist, William Olser Health Centre Brampton, Ontario, Canada

Joshua M. Hare, M.D., F.A.C.C.
Professor of Medicine and Biomechanical Engineering; Director, Heart Failure and Cardiac Transplantation; Director, Cardiovascular Section, Institute for Cell Engineering, Johns Hopkins University School of Medicine Baltimore

Sharon Ann Hunt, M.D., F.A.C.C.
Professor, Cardiovascular Medicine, Stanford University Stanford, Calif.

Silviu M. Itescu, M.D.
Associate Professor, Departments of Surgery and Medicine; Director, Transplantation Immunology, Columbia University New York

Stuart D. Katz, M.D., F.A.C.C.
Associate Professor, Department of Medicine, Yale University, Yale New Haven Hospital New Haven, Conn.

Marvin A. Konstam, M.D., F.A.C.C.
Chief of Cardiology, Professor of Medicine, Tufts-New England Medical Center Boston

Eva Lonn, M.D., M.Sc., F.R.C.P.(C.), F.A.C.C.
Professor of Medicine, McMaster University; Staff Cardiologist, Hamilton Health Sciences-General Site Hamilton, Ontario, Canada

Alan S. Maisel, M.D., F.A.C.C.
Professor of Medicine, University of California San Diego; Director CCU and CHF Program, San Diego VA Health Care System San Diego

Douglas L. Mann, M.D., F.A.C.C.
Gordon Cain Chair and Professor of Medicine; Director, Winters Center for Heart Failure Research, Baylor College of Medicine Houston

Kenneth B. Margulies, M.D., F.A.C.C.
Associate Professor of Medicine & Physiology, Temple University School of Medicine Philadelphia

Dennis M. McNamara, M.D., F.A.C.C.
Associate Professor of Medicine; Director, Heart Failure/Transplantation Program, University of Pittsburgh Medical Center Pittsburgh

Christopher J. O’Donnell, M.D., F.A.C.C.
Associate Director, NHLBI’s Framingham Heart Study Medical Officer, National Heart, Lung, and Blood Institute; Attending Cardiologist, Massachusetts General Hospital; Assistant Professor, Harvard Medical School Boston

Ileana L. Pina, M.D., F.A.C.C.
Professor of Medicine Case, Western Reserve University; Director of Heart Failure and Cardiac Transplantation, Division of Cardiology, University Hospitals of Cleveland Cleveland

Richard J. Rodeheffer, M.D., F.A.C.C.
Professor or Medicine, Mayo Medical School Rochester, Minn.

Hani N. Sabbah, Ph.D., F.A.C.C.
Professor of Medicine; Director, Cardiovascular Research, Henry Ford Health Services Detroit

Francis G. Spinale, M.D., Ph.D., F.A.C.C.
Professor and Vice Chair Department of Surgery, Medical University of South Carolina Charleston, S.C.

Anthony S.L. Tang, M.D., F.R.C.P.(C.), F.A.C.C.
Professor of Medicine, Director of Electrophysiology, Director of Cardiology Research, University of Ottawa Heart Institute Ottawa, Ontario, Canada

Robin J. Trupp, M.S.N., A.C.N.P., C.C.R.N., C.C.R.C.
Heart Failure Program Director, Ohio State University Columbus, Ohio

Michel White, M.D., F.R.C.P.(C.), F.A.C.C.
Director, Heart Failure Research Program, Montreal Heart Institute, University of Montreal Montreal

Michael R. Zile, M.D., F.A.C.C.
Charles Ezra Daniel Professor of Medicine, Medical University of South Carolina Charleston, S.C.

The Eighth Annual
Toronto International Heart Failure Summit: From Pathophysiology to Clinical Practice —2005

Directed by Peter P. Liu, M.D., F.R.C.P. (C.), F.A.C.C., and John D. Parker, M.D., F.R.C.P.(C.), F.A.C.C.

Offered in cooperation with the Heart & Stroke/Richard Lewar Centre for Cardiovascular Research at the University of Toronto, focusing on novel advances in pathophysiology and therapeutics in the post-genome era.

June 5-7, 2005
Toronto, Ontario, Canada

Program Overview & Objectives
Heart Failure is the largest rising epidemic in cardiovascular disease and is associated with high mortality and burden to health care and society. Despite the tremendous advances in the last decades, including novel drugs and devices, the predominant pathophysiology of heart failure still remains to be elucidated. There also remains a large gap between the knowledge and trial evidence and the actual impact on quality of life and survival. Novel health delivery methods such as heart failure clinics, guideline implementation tools and interdisciplinary teams may help to bridge this gap.

The purpose of this conference is to bring together the most exciting advances from the basic to the clinical arena of congestive heart failure. This program is also unique in that the fundamental understanding and clinical application are juxtaposed in a coordinated fashion. This serves to emphasize the seamless continuum from basic investigation to clinical practice.

To enhance the learning experience, the meeting features lectures, interactive keypad response systems, problem solving sessions and case presentations to enhance the interaction between the faculty and the participants. The workshops are particularly valuable in translating the concepts to practice to individual cases and observing how guidelines are applied to practice.

Upon completion of this program, attendees should be able to —

  • understand the molecular and functional processes that contribute to the failing heart
  • understand the basic mechanism of left ventricular remodeling and new pathways leading to heart failure
  • recognize the diagnostic approach to the etiology of heart failure and its contributing causes
  • develop a state-of-the-art multidisciplinary approach to heart failure management
  • determine the role of devices in the treatment of heart failure
  • review the clinical epidemiology and treatment strategies for heart failure, including both medical and surgical options

Who Should Attend

  • Cardiovascular specialists
  • Internists
  • Allied health professionals
A special venue will be available for course attendees and their guests the evening of June 6. Tickets will be available at the registration desk on a first-come, first-served basis. Transportation, dinner and entertainment will be provided. Complimentary tickets for course registrants: $35 (cash or cheque) for guests of registrants. Dress code: Business Attire.

 

ADVERTISEMENT








Back to Top | | Copyright © 2008 American College of Cardiology
ACCInTouch Facebook Twitter LinkedIn
Heart House | 2400 N Street, NW | Washington, DC 20037